The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset Dementia. van der Doelen DM, Handels RLH, Zwan MD, van Kuijk SMJ, et al. Alzheimer Dis Assoc Disord 2022;36:1-6.

Read + Share

Amedeo Smart

Independent Medical Education

van der Doelen DM, Handels RLH, Zwan MD, van Kuijk SMJ, et al. The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset Dementia. Alzheimer Dis Assoc Disord 2022;36:1-6.
PMID: 35200198